|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 31/00 |
| (11) | Number of the document | 3242678 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16700138.7 |
| Date of filing the European patent application | 2016-01-08 | |
| (97) | Date of publication of the European application | 2017-11-15 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/050321 |
| Date | 2016-01-08 |
| (87) | Number | WO 2016/110593 |
| Date | 2016-07-14 |
| (30) | Number | Date | Country code |
| 201500374 | 2015-01-09 | GB |
| (72) |
TRIEBEL, Frédéric, FR
BRIGNONE, Chrystelle, FR
|
| (73) |
Immutep S.A.S.,
Parc Club Orsay 2 Rue Jean Rostand, 91400 Orsay,
FR
|
| (54) | COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION |
| COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION |